Dr. Kam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1341 W Mockingbird Ln
Ste 200
Dallas, TX 75247Phone+1 214-647-9305
Education & Training
- Kaiser Permanente Northern California (San Francisco)Residency, Obstetrics and Gynecology, 2005 - 2007
- Cedars-Sinai Medical CenterInternship, Transitional Year, 2004 - 2005
- University of Hawaii, John A. Burns School of MedicineClass of 2004
Certifications & Licensure
- HI State Medical License 2008 - 2026
- TX State Medical License 2013 - 2026
- CA State Medical License 2006 - 2025
- WA State Medical License 2013 - 2025
Clinical Trials
- Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Start of enrollment: 2020 Sep 09
Publications & Presentations
PubMed
- 9 citationsEvaluation of Potential Drug-Drug Interaction Between Delayed-Release Dimethyl Fumarate and a Commonly Used Oral Contraceptive (Norgestimate/Ethinyl Estradiol) in Heal...Bing Zhu, Ivan Nestorov, Guolin Zhao, Venkata Meka, Mark Leahy
Clinical Pharmacology in Drug Development. 2017-08-07 - 7 citationsEffects of strong and moderate CYP3A4 inducers on the pharmacokinetics of fedratinib in healthy adult participantsKen Ogasawara, Jeanelle Kam, Mark Thomas, Liangang Liu, Mary Liu
Cancer Chemotherapy and Pharmacology. 2021-05-21 - 15 citationsDose-dependent acute liver injury with hypersensitivity features in humans due to a novel microsomal prostaglandin E synthase 1 inhibitor.Y. Jin, Arie Regev, Jeanelle Kam, Krista M Phipps, Claire Smith
British Journal of Clinical Pharmacology. 2018-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: